MYM Nutraceuticals Inc. (OTCQB: MYMMF) (CSE: MYM.CN) News - September 26, 2018

MYM Partners with Award-Winning Dutch Passion for the Production and Distribution of Cannabis Seeds in Canada

Vancouver, B.C., September 26, 2018 – MYM Nutraceuticals Inc., (OTCQB: MYMMF) (CSE: MYM) (the “Company” or “MYM”) is pleased to announce that it has entered into an agreement with Amsterdam-based Dutch Passion Seed Company for the production and distribution of Dutch Passion branded products and seed genetics in Canada. This follows the August announcements of similar agreements between Dutch Passion and MYM for production and distribution of branded products and seed genetics in Australia and Colombia.

Established in 1987, Dutch Passion is the second-oldest European Cannabis seed company and for over 30 years has been a leading innovator of seed genetics. Dutch Passion has developed its own proprietary genetics and owns a seed collection of international cannabis genetics dating back to the 1970s. The company has won more than 50 Cannabis Cups for its high-THC, easy-to-grow varieties. Dutch Passion also invented feminized cannabis seeds in the 1990s and, more recently, helped pioneer the success of high-THC auto-flowering cannabis seeds.

“We are thrilled to be working with Dutch Passion in Australia, Colombia and now Canada. With over 30 years’ experience in the development and distribution of cannabis seeds, they are widely recognized as world leaders,” said Rob Gietl, CEO of MYM. “As legal production of cannabis has been rapidly increasing worldwide, so has the demand for seed genetics. The Dutch Passion portfolio of seeds will prove to be a very valuable asset to MYM and its shareholders.”

Eric Siereveld, CEO of Dutch Passion commented, “There were a lot of options when we were considering working with producers in Canada. We chose to partner with MYM because of their strong network and organization in the global cannabis industry. We are confident that MYM has the best environment to maximize the potential of the genetic products we offer.”

Dutch Passion agrees to give MYM exclusive rights in Canada to produce and distribute under the Dutch Passion brand, all products that Dutch Passion sells currently and may sell in the future, including: clones, flowers, pre-rolled joints and other cannabis products. Dutch Passion also agrees to give MYM non-exclusive rights in Canada to produce and/or distribute cannabis seeds under the Dutch Passion brand.

MYM will make Dutch Passion its flagship brand of cannabis seeds for sale in Canada and Dutch Passion will list MYM as an official distributor of products in Canada.
Dutch Passion will allow MYM and its subsidiaries access to all its seed strains for MYM’s breeding and production programs and will provide Dutch Passion a 1000 square-metre section in their production facility to co-develop new genetics.

MYM agrees to reproduce bulk seeds of Dutch Passion’s proprietary strains for resale to Dutch Passion exclusively, based on advance purchase orders including mutually agreed upon pricing, to be determined. MYM also agrees to produce improved auto-flowering strains for Dutch Passion’s catalog. Dutch Passion agrees to purchase seeds from these strains.

About Dutch Passion
Dutch Passion is a Dutch company with over 30 years’ experience in the development and distribution of cannabis seeds. Dutch Passion is focused on producing high quality, high-THC cannabis genetics and on providing attentive customer service through its experienced customer service team. Dutch Passion’s diverse seed collection of international cannabis genetics dates back to the 1970s, with all varieties having passed strict tests designed to ensure ease of growth, heavy yields and high-quality results. In the 1990s, Dutch Passion invented feminized cannabis seeds and, more recently, helped to pioneer the success of high-THC auto-flowering cannabis seeds. www.dutch-passion.com

About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end medicinal cannabis supplements and topical products. MYM is a shareholder in two production projects in Québec that when completed are anticipated to have over 1.5 million square feet of production space. MYM also has interest in two international cannabis production projects in Australia and Colombia. In New South Wales, Australia, the “Northern Rivers Project” is expected to have 1.2 million square feet of cannabis production space. In Medellin, Colombia, MYM and Colombia Organica are planning to build a cannabis production facility in the region. Colombia Organica currently holds a seed-to-sale license for low-THC cannabis, which permits the company to grow, produce and create cannabis derivatives to be commercialized and/or exported. Colombia Organica is in the licensing process for the cultivation and production of high-THC cannabis extracts. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE BOARD
Rob Gietl, CEO
MYM Nutraceuticals Inc.
www.mym.ca
Investor Relations
investors@mym.ca

Keep up to date with MYM on our social media channels:
Twitter: @mymnutra
Facebook: @mymnutra
Instagram: @mymnutra

This release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the production and distribution of Dutch Passion branded products in Colombia and Australia, the anticipated access to and commercial value of Dutch Passion’s list of seeds and cannabis products, the anticipated combined production space of 1.5 million square feet for the two production projects in Quebec, the anticipated 1.2 million square feet of production space in the Northern Rivers Project, and the building of a cannabis production facility in Colombia. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends,” “anticipates,” “it is expected,” or variations of such words and phrases, or statements that certain actions, events or results “may,” “could,” “should,” or “would” occur. Forward-looking statements are based on certain material assumptions and analyses made by the Company and the opinions and estimates of management as of the date of this press release, including the assumption that the terms and conditions of the agreements with Dutch Passion will be carried out and satisfied as anticipated, that MYM will have access to Dutch Passion’s list of seeds and cannabis products and that it will be a commercially valuable asset, that the Northern Rivers Project will be completed as planned, including the construction and operation of 1.2 million square feet of production space, that MYM’s projects in Quebec will be completed as planned, with 1.5 million square feet of greenhouse space, and that the cannabis production facility will be successfully built near Medellin, Colombia as anticipated by MYM. Although the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, the risk that the terms and conditions of the agreements with Dutch Passion will not be carried out or satisfied as anticipated, or at all, that MYM will not have access to Dutch Passion’s list of seeds and cannabis products due to unforeseen complications or, if it does, that such list of seeds and cannabis products will not be commercially valuable, MYM’s Quebec projects will not be successfully built as planned, the Northern Rivers Project will not be successfully built as planned, the cannabis production facility will not be successfully built as planned, and the other risks and uncertainties applicable to the Company's business as set forth in the Company's management discussion and analysis and annual information form and the Company’s other disclosure available under the Company's profile at www.sedar.com. There can be no assurance that the transactions contemplated in this news release will complete. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that is incorporated by reference herein, except in accordance with applicable securities laws.

Media Contact:
Investor Relations
Terry Brown
+1-855-696-2261
terry.brown@mym.ca

SOURCE MYM Nutraceuticals Inc.

MYM Construction Update on Weedon, Quebec Greenhouse Project

Vancouver, B.C., September 5, 2018 – MYM Nutraceuticals Inc., (OTCQB: MYMMF) (CSE: MYM) (the “Company” or “MYM”) is pleased to provide the following update on its, currently under construction, 1.5 million sq. ft. cannabis greenhouse production facility, located in Weedon, Quebec.

A significant portion of the property is currently cleared and de-stumped. There is now ample land to construct the first phase of greenhouses. The project has accepted delivery of the first 30,000 sq. ft. of greenhouse structure and equipment and will begin construction immediately. Phase one of the greenhouse construction is estimated to be completed in September. The equipment and control systems are scheduled to be installed in October. Following this, the virtual tour and evidence package video will be completed and delivered to Health Canada in Q4 2018.

Clearing of the land for phase two will occur concurrent with the construction of the first phase of greenhouses. The foundations and anchor points will be in place by the end of 2018. The estimated date for the project build-out is Q4 of 2019, with full production of the 1.5 million sq. ft. greenhouse facility estimated to be underway in Q2 of 2020

Hydro Quebec’s pre-engineering and planning process is in motion on the property. Their next step is to send procurement needs for the implementation of power to the greenhouse project. There is now a clear plan for delivery of the necessary power required for the site.

Environment Quebec is currently processing the project’s Certificate of Authorization that allows construction to take place within the close-proximity of the property’s protected wetlands. The project will continue to make every effort to ensure its building practices support environmental sustainability.

The Company has recently partnered with three different institutions in the area to both widen community ties and provide an educational aspect to the project:

MYM’s partnership with the University of Sherbrooke will focus on the medicinal and industrial uses of cannabis and hemp. Researchers at the University of Sherbrooke will work with an on-site coordinator to create partnerships by targeting expertise in various faculties and training centres.

The partnership agreement with Sherbrooke College (CEGEP) will see the development of a training program for the project’s employees assigned to the production of cannabis. The educational curriculum will be expanded and offered as a diploma (AEC) program as part of the Sherbrooke College (CEGEP) course offerings.

Lastly, MYM’s partnership with the Sherbrooke Historical Society will create the concept for the CannaCentre museum, which is expected to be built at the Company’s planned 1.5 million sq. ft. cannabis production facility in Weedon, Quebec. The facility will integrate research and development, academia, tourism, and community initiatives.

Please visit http://www.mym.ca/weedon-quebec/  or follow us on social media for updated photos of the project. Check back often as we’ll be posting new photos on a regular basis.

About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end medicinal cannabis supplements and topical products. MYM is a shareholder in two production projects in Quebec that are anticipated to have over 1.5 million square feet of production space. MYM is also a shareholder in two additional cannabis production projects in Australia and Colombia. The “Northern Rivers Project” in New South Wales, Australia is expected to have 1.2 million square feet of cannabis production space. In Colombia, MYM partner, Colombia Organica, currently hold a seed to sale license for low THC cannabis and are in the licensing process for the cultivation and production of high THC cannabis extracts. Plans are underway for MYM and Colombia Organica to build a cannabis production facility in the region. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE BOARD
Rob Gietl, CEO
MYM Nutraceuticals Inc.
www.mym.ca
Investor Relations
Terry Brown
1.855.696.2261
terry.brown@mym.ca
Keep up to date with MYM on our social media channels:
Twitter: @mymnutra
Facebook: @mymnutra
Instagram: @mymnutra

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the secu-rities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the se-curities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

Media Contact:
Investor Relations
Terry Brown
+1-855-696-2261
terry.brown@mym.ca

SOURCE MYM Nutraceuticals Inc.

MYM Enters Into Research Partnership With the University of Sherbrooke

Vancouver, B.C., August 24, 2018 – MYM Nutraceuticals Inc., (OTCQB: MYMMF) (CSE: MYM) (the “Company” or “MYM”) is pleased to announce it has entered into a partnership with the University of Sherbrooke to study the medicinal and industrial uses of cannabis and hemp. Researchers at the University of Sherbrooke will work with an on-site coordinator to create partnerships by targeting expertise in various faculties and training centres.

During cannabis prohibition, research on its compounds and by-products remained very limited. This partnership aims to explore the benefits of the cannabis plant. "Université de Sherbrooke groups together a broad set of skills in relation to the opportunities associated with cannabis," said Vincent Aimez, Vice-President, Commercialization and Partnerships, University of Sherbrooke. "MYM's contribution will help actively explore multiple research projects. This is a completely new and highly promising multidisciplinary partnership we wish to nurture and grow in the coming years."

Avenues of collaboration range from identifying the best alternative energy systems in greenhouses to the effects of cannabinoids on the nervous and immune systems. Research will also include: industrial materials manufacturing, eco materials, hemp fiber biofuels and opportunities created from the by-products of cannabis production.

"The signing of this partnership agreement with University of Sherbrooke furthers our goal to be at the forefront of cannabis plant research and development," said Rob Gietl, CEO of MYM. "Furthermore, I am delighted to see our company associated with a large Quebec university that has an outstanding reputation in research and innovation."

Charith Adkar, MYM's Chief Science Officer commented "I believe that this innovative agreement with the University of Sherbrooke will allow our company to achieve its objectives in research and development in connection with our medical cannabis-based products. We have much to do to demonstrate the relevance of prescribing medical cannabis to deal with health problems. In this respect, research is an important lever to show the usefulness of our products relative to health issues."

About University of Sherbrooke

University of Sherbrooke is at the heart of one of Quebec's three major research poles. Known for its spirit of innovation, U of S partners with all levels of government to promote social, cultural and economic development. The U of S enjoys strong growth in research activities as has been demonstrated over the past years. The U of S excels in technology transfer and initiatives focused on entrepreneurship and innovation in collaboration with the industrial and social communities.

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end medicinal cannabis supplements and topical products. MYM is a shareholder in two production projects in Quebec that are anticipated to have over 1.5 million square feet of production space. MYM is also a shareholder in two additional cannabis production projects in Australia and Colombia. The "Northern Rivers Project" in New South Wales, Australia is expected to have 1.2 million square feet of cannabis production space. In Colombia, MYM partner, Colombia Organica, currently hold a seed to sale license for low THC cannabis and are in the licensing process for the cultivation and production of high THC cannabis extracts. Plans are underway for MYM and Colombia Organica to build a cannabis production facility in the region. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC: MYMMF) (FRA: 0MY) (DEU: 0MY) (MUN:0 MY) (STU: 0MY).

ON BEHALF OF THE BOARD
Rob Gietl, CEO
MYM Nutraceuticals Inc.
www.mym.ca

Keep up to date with MYM on our social media channels:

Twitter: @mymnutra
Facebook: @mymnutra
Instagram: @mymnutra

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

Media Contact:
Investor Relations
Terry Brown
+1-855-696-2261
terry.brown@mym.ca

SOURCE MYM Nutraceuticals Inc.

MYM Engages Tourism Management Expert to Develop Concept for CannaCentre in Weedon, Quebec

Vancouver, B.C., August 14, 2018 – MYM Nutraceuticals Inc., (OTCQB: MYMMF) (CSE: MYM) (the “Company” or “MYM”) is pleased to announce it as engaged well-known tourism and recreational expert, Sylvain Audet, to develop the concept of the CannaCentre in Weedon, QC. The CannaCentre is associated with the Company's 1.5 million square foot medical cannabis greenhouse complex currently under construction in Weedon, Quebec. The CannaCentre will host a research centre, a training facility, an auditorium for cultural and scientific activities, a hotel, a restaurant, a medical cannabis interpretation centre and a medical clinic.

Mr. Audet will work in close collaboration with the Sherbrooke Historical Society to develop the concept of the medical cannabis museum as part of the CannaCentre. Mr. Audet is tasked with identifying the primary, indirect and complementary clientele targets, to suggest services and activities complementary to the project's infrastructure and evaluate the profitability of the overall project.

"The addition of Sylvain Audet provides the project with the expertise for a harmonious tourism and cultural development," said Rob Gietl, CEO of MYM. "Mr. Audet's expertise will allow the region to offer a world-class tourism product that is in line with the needs of the local population."

Mr. Audet's experience includes positions with high-end hotels and resorts, regional organizations promoting tourism and ski resorts in the Eastern Townships. Mr. Audet has more than twenty-five years-experience as a recreational tourism consultant for several companies and regional organizations in Canada. He has acquired extensive expertise in tourism brand development, financial benchmarking analysis, marketing research and business plan development in several recreational tourism fields.

Mr. Audet is currently an instructor at the Université du Quebec à Montreal (UQAM) in the institution's Hospitality and Tourism Management program. Mr. Audet holds a Master of Business Administration (MBA) from Université Laval (Quebec City) and a Bachelor of Business Administration (BAA) in Management and Tourism Intervention from UQAM. Mr. Audet is currently working on a PhD in Business Administration (DBA) at the Heriot-Watt University's Edinburgh Business School (Scotland).

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end medicinal cannabis supplements and topical products. MYM is a shareholder in two production projects in Quebec that are anticipated to have over 1.5 million square feet of production space. MYM is also a shareholder in two additional cannabis production projects in Australia and Colombia. The "Northern Rivers Project" in New South Wales, Australia is expected to have 1.2 million square feet of cannabis production space. In Colombia, MYM partner, Colombia Organica, currently hold a seed to sale license for low THC cannabis and are in the licensing process for the cultivation and production of high THC cannabis extracts. Plans are underway for MYM and Colombia Organica to build a cannabis production facility in the region. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE BOARD
Rob Gietl, CEO
MYM Nutraceuticals Inc.
http://www.mym.ca

Keep up to date with MYM on our social media channels:

Twitter: @mymnutra
Facebook: @mymnutra
Instagram: @mymnutra
Linkedin: @mymnutra

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on http://www.sedar.com.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

Investor Relations
Terry Brown
+1-855-696-2261
terry.brown@mym.ca

SOURCE MYM Nutraceuticals Inc.

MYM Partners with Award Winning Dutch Passion for the Production and Distribution of Cannabis Seeds in Colombia

Vancouver, B.C., August 8, 2018 – MYM Nutraceuticals Inc., (OTCQB: MYMMF) (CSE: MYM) (the “Company” or “MYM”) is pleased to announce it has entered into an agreement with Amsterdam based Dutch Passion for the production and distribution of Dutch Passion branded products and seed genetics in Colombia. This follows the August 1 announcement of a similar agreement between Dutch Passion and MYM for production and distribution of branded products and seed genetics in Australia.

Established in 1987 Dutch Passion is the second oldest European Cannabis seed company and for over 30 years has been a leading innovator of seed genetics. Dutch Passion has developed its own proprietary genetics and owns a seed collection of international cannabis genetics dating back to the 1970s. Since Dutch Passion was established in 1987, the company has won more than 50 Cannabis Cups for its high-THC, easy-to-grow varieties. Dutch Passion also invented feminized cannabis seeds in the 1990s and, more recently, helped pioneer the success of high-THC auto-flowering cannabis seeds.

“We are thrilled to be working with Dutch Passion in both Australia and Colombia. With over 30 years-experience in the development and distribution of cannabis seeds, they are considered to be world leaders,” said Rob Gietl, CEO of MYM. “As legal production of cannabis has been rapidly increasing worldwide, so has the demand for seed genetics. The Dutch Passion portfolio of seeds will prove to be a very valuable asset to the shareholders of MYM.”

Eric Siereveld, CEO of Dutch Passion Seed Company commented, “There were a lot of options when we were considering working with producers in Colombia. We chose to partner with MYM because of their strong network and organization in the global cannabis industry. We are confident that MYM has the best environment to maximize the potential of the genetic products we offer.”

Dutch Passion agreed to give MYM exclusive rights in Colombia to produce and distribute under the Dutch Passion brand, all products that Dutch Passion sells currently and may sell in the future, including: clones, flowers, pre-rolled joints and other cannabis products. Colombia is poised to be one of the world’s leading exporters of Cannabis products due to its favorable growing environment and low production costs. Dutch Passion also agreed to give MYM non-exclusive rights in Colombia to produce and/or distribute cannabis seeds under the Dutch Passion brand.

MYM agreed to make Dutch Passion its flagship brand of cannabis seeds for sale in Colombia and Dutch Passion agreed to list MYM as an official distributor of products in Colombia.

About Dutch Passion
Dutch Passion is a Dutch company with over 30 years’ experience in the development and distribution of cannabis seeds. Dutch Passion is focused on producing high quality, high-THC cannabis genetics and on providing attentive customer service through its experienced customer service team. Dutch Passion’s diverse seed collection of international cannabis genetics dates back to the 1970s, with all varieties having passed strict tests designed to ensure ease of growth, heavy yields and high-quality results. In the 1990s, Dutch Passion invented feminized cannabis seeds and, more recently, helped to pioneer the success of high-THC auto-flowering cannabis seeds. www.dutch-passion.com

ON BEHALF OF THE BOARD
Rob Gietl, CEO
MYM Nutraceuticals Inc.
www.mym.ca

Investor Relations
Terry Brown
1.855.696.2261
terry.brown@mym.ca

Keep up to date with MYM on our social media channels:

Twitter: @mymnutra
Facebook: @mymnutra
Instagram: @mymnutra

About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end medicinal cannabis supplements and topical products. MYM is a shareholder in two production projects in Quebec that when completed are anticipated to have over 1.5 million square feet of production space. MYM is also a shareholder in two international cannabis production projects in Australia and Colombia. In New South Wales, Australia, the “Northern Rivers Project” is expected to have 1.2 million square feet of cannabis production space. In Medellin, Colombia, MYM and Colombia Organica have partnered and are planning to build a cannabis production facility in the region. Colombia Organica currently holds a seed to sale license for low THC cannabis which permits the company to grow, produce and create cannabis derivatives to be commercialized and / or exported. Colombia Organica is in the licensing process for the cultivation and production of high THC cannabis extracts. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

This release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the production and distribution of Dutch Passion branded products in Colombia and Australia, the anticipated access to and commercial value of Dutch Passion’s list of seeds and cannabis products, the anticipated combined production space of 1.5 million square feet for the two production projects in Quebec, the anticipated 1.2 million square feet of production space in the Northern Rivers Project, and the building of a cannabis production facility in Colombia. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends,” “anticipates,” “it is expected,” or variations of such words and phrases, or statements that certain actions, events or results “may,” “could,” “should,” or “would” occur. Forward-looking statements are based on certain material assumptions and analyses made by the Company and the opinions and estimates of management as of the date of this press release, including the assumption that the terms and conditions of the agreements with Dutch Passion will be carried out and satisfied as anticipated, that MYM will have access to Dutch Passion’s list of seeds and cannabis products and that it will be a commercially valuable asset, that the Northern Rivers Project will be completed as planned, including the construction and operation of 1.2 million square feet of production space, that MYM’s projects in Quebec will be completed as planned, with 1.5 million square feet of greenhouse space, and that the cannabis production facility will be successfully built near Medellin, Colombia as anticipated by MYM. Although the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, the risk that the terms and conditions of the agreements with Dutch Passion will not be carried out or satisfied as anticipated, or at all, that MYM will not have access to Dutch Passion’s list of seeds and cannabis products due to unforeseen complications or, if it does, that such list of seeds and cannabis products will not be commercially valuable, MYM’s Quebec projects will not be successfully built as planned, the Northern Rivers Project will not be successfully built as planned, the cannabis production facility will not be successfully built as planned, and the other risks and uncertainties applicable to the Company's business as set forth in the Company's management discussion and analysis and annual information form and the Company’s other disclosure available under the Company's profile at www.sedar.com. There can be no assurance that the transactions contemplated in this news release will complete. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that is incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.

Investor Relations
Terry Brown
+1-855-696-2261
terry.brown@mym.ca

SOURCE MYM Nutraceuticals Inc.

-------------------------------------------------------------------
About MYM Nutraceuticals Inc.:

LOOKING BEYOND THE TOMORROW TO ENVISION AND CRAFT A NEW INDUSTRY
Building a brand new industry is no small feat to be taken lightly. Our team of visionaries have an unbeatable track record of successful startups and have extensive experience in emerging markets. The MYM Nutraceuticals team is building a foundation in the medical marijuana sector that will set the company apart from its competitors with a focus on marijuana growing technology, perfecting our brands and distribution strategies.

- What does the market want?
- Where will the market go?
- What does it look like in 10 years?
- What other businesses will benefit?
- How can we enter the USA market
- What does distribution look like?
- How can we innovate?
- How will legalization change everything?
- What can we learn from prohibition?
- How can we leverage partnerships?
- What is the best way to educate our customers?
- What are our goals for research and development?
- What other products can we develop?
- What will set our brands apart from others?
- How can we do it better?

While many companies are now just trying to answer these questions, the MYM Nutraceuticals team for the past 9 years has been working on the answers and creating solutions. Nine years of research, analytics, brain storming, field experience and market research has resulted in a unified company vision that will build a company unlike any other in the industry. Through innovation, advanced distribution and creative marketing MYM Nutraceuticals is leading the charge of this exciting new industry.

MYM Nutraceuticals Inc. is an emerging bio-pharmaceutical company and distributor of medical marijuana products that has applied to Health Canada for a medical marijuana production and distribution license under the Marihuana for Medical Purposes Regulations. MYM Nutraceuticals has an extensive list of industry assets that make it well prepared for commercial distribution of medical marijuana, including a growing facility property, exclusive access to patients and many years of industry expertise on the company’s board of directors and staff.

Licensed Production |

We are currently in the application process in Canada and the USA for medical marijuana

Growing Technology |

Our team has over 30 years of growing experience to create higher quality products.

Brand Marketing |

We are reinventing current branding & marketing strategies within legalized Marijuana.

Distribution |

We are using technology to build out innovative distribution systems and networks.

What We Do HomeWhat We Do
MYM Nutraceuticals is focused on building and/or acquiring and growing businesses in the Marijuana sector.

These are our business divisions:

MYM Nutraceuticals

MYM Nutraceuticals – This is the umbrella corporation that will look to invest and develop its own brands as well as capitalize
on other established brands once we have secured our Health Canada license for cannabis production. MYM will use the
knowledge and experience of its management team to create new brands and bring in assets that will help the company grow rapidly

Sublime growers
Sublime – This newly acquired company will facilitate the production and distribution of cannabis products initially through production in a 10,000 SF
facility located in the Montreal area with further expansion to 36,000 SF within the next 18-24 months. Sublime has progressed to the final
two stages of the production licensing application process of the ACMPR. A final inspection is set for August 2017. This brand
will offer high end Indica and Sativa Cannabis products for sale to our patients as well as high end Co2 extracted oils (concentrates).

HempMed CBD

HempMed – This Line features our most advanced line of cannabis products. These are tailored products that combine just the right amounts of CBD for specific ailments. Whether it’s pain relief, calming seizures, relieving the symptoms of Crones disease or aiding in the recovery of Chemotherapy treatments, this product line will change the lives of people fed up with harmful pharmaceutical products.

MyHemp

My Hemp – This brand will lay the foundation for our life style products by establishing our brand as a true household
name. We are creating unique products into a rapidly growing marketplace that appeal to both men and women.

Our Team

CEO, Rob Gietl
Mr. Gietl is well known for his ability to exponentially grow businesses including the west-coast franchise expansion of Domino’s Pizza, where he consistently grew the annual business to achieve 300+% increases year-over-year.
Mr. Gietl is a seasoned Business Development and Operations executive with a diverse track record of leading change across all areas of concept creation, brand re-positioning, market penetration, fiscal accountability and efficient execution of business plans. He has grown business effectiveness in an array of sectors and circumstances throughout Canada, consistently aligned with stakeholders’ goals and values

Mr. Gietl is a seasoned Business Development and Operations executive with a diverse track record of leading change across all areas of concept creation, brand re-positioning, market penetration, fiscal accountability and efficient execution of business plans. He has grown business effectiveness in an array of sectors and circumstances throughout Canada, consistently aligned with stakeholders goals and values.

Director of Operations, Jonathan Fiteni
Jonathan Fiteni has over 14 years of experience in the medical marijuana industry in general, and in product development and construction of marijuana facilities in particular. Mr. Fiteni is very educated and experienced in producing medical quality marijuana strains from seed to patient. He has designed and managed the building of numerous high-density growing facilities, requiring stringent construction standards. Using hydroponics and other sophisticated growing methods, he has successfully integrated complex electrical, dehumidification, HVAC and irrigation systems together to produce high quality organic marijuana products.

Director, Ian Ramage
Ian Ramage holds a B.A.Sc. in Computer Engineering from Simon Fraser University and J.D. and LL.M. degrees from the University of British Columbia. He practiced law in the Bay Area for eight years for a variety of biotech and high-tech clients before returning to Vancouver in 2009 to continue to build his corporate and securities practice. Mr. Ramage is an expert in Canadian and U.S securities and corporate law; copyright and trademark acquisition and enforcement; patent, copyright, and trade secret litigation.

Chief Financial Officer, Mark Forster
Mark Forster will be responsible for the preparation of financial statements, continuing disclosure of the Resulting Issuer and the management of internal control procedures. He has over 25 years of financial accounting experience in banking, manufacturing of beer, wine, and spirits, the oil and gas industry and in the mining sector. He has been a director and the CFO of Teletouch Services Inc., a private technology company, since December 2004. He was a manager of Bearingpoint LLP, a management and technology company, from January 1996 to December 2006. Mark G. Forster was granted a CGA designation by the Certified General Accountant’s Association, BC in 1992.

Investor Relations

MYM Investor Relations Contact info:
Terry Brown
Tel: 1-855-696-2261

You can email Mr. Brown here: http://www.mymarijuana.ca/contact-us/

MYM Nutraceuticals Inc. CSE:MYM OTC:MYMMF FRA:0MY, is a bio-pharmaceutical company focused on production, distribution, innovation, technology and branded products related to the Marijuana industry. Our executive team has built numerous successful companies from the ground up and are striving to make MYM a world class brand.

The MYM Nutraceuticals team has been working in the medical marijuana industry for many years and now that the Canadian and USA markets are starting to open up, they are putting their vast experience to work. The company is leveraging the teams extensive and successful business experience to innovate this brand new exciting industry. The rapid and expansive growth predicted for the industry is staggering and we believe that our visionary team have the background and motivation for MYM Nutraceuticals to become the market leader.

SOURCE: http://mymarijuana.ca/

Disclaimer